A new grant will allow Michigan Medicine researchers to explore personalized approaches to treating autoimmune diseases such as scleroderma, lupus, rheumatoid arthritis and others.
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients.
A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.
U-M researchers are studying an overabundant signaling protein tied to UV light sensitivity in patients with lupus.
A new study from researchers at Michigan Medicine explores links between chronic joint inflammation and cognitive impairment.